已收盘 02-06 16:00:00 美东时间
+2.210
+3.11%
今日重点评级关注:康托·菲茨杰拉德:维持Wave Life Sciences Ltd."超配"评级,目标价从34美元升至41美元;Piper Sandler:维持Replimune Group"超配"评级,目标价从13美元升至14美元
02-06 16:52
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
02-05 11:28
Stifel analyst Shlomo Rosenbaum maintains Amdocs (NASDAQ:DOX) with a Buy and lowers the price target from $97 to $88.
02-04 21:13
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Amdocs 2026财年第一季度业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** Q1营收11.6亿美元,同比增长4.1%,按固定汇率计算增长3.5%,略高于指导区间中点。其中托管服务收入7.46亿美元,同比增长2.3%,占总收入约65%。 **盈利能力:** Non-GAAP营业利润率21.6%,同比提升40个基点,环比持平。Non-GAAP摊薄每股收益1.81美元,超出指导区间,主要受益于低于预期的税率。GAAP摊薄每股收益1.45美元,包含每股0.09美元的重组费用。 **现金流状况:** 重组支付前自由现金
02-04 12:34
Amdocs (NASDAQ:DOX) announced its Q1 earnings on Tuesday, February 3, 2026 at 0...
02-04 05:39
Amdocs shares are trading higher after the company reported better-than-expecte...
02-04 05:36
The Q1 earnings report for Amdocs (NASDAQ:DOX) was released on Tuesday, Februar...
02-04 05:24
Amdocs (NASDAQ:DOX) released its Q1 earnings on Tuesday, February 3, 2026 at 04...
02-04 05:04
Amdocs (NASDAQ:DOX) reported quarterly earnings of $1.81 per share which beat the analyst consensus estimate of $1.76 by 2.96 percent. This is a 9.04 percent increase over earnings of $1.66 per share from the same period
02-04 05:03
Companies Reporting Before The Bell • Atkore (NYSE:ATKR) is expected to report ...
02-03 19:11